This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2015
AUA 2015
- Prostate Cancer
- mCRPC Treatment
- Genomics
- mCRPC Radiotherapy
- Bone Metastases
- Bladder Cancer
- Renal Cancer
- Endourology
- Testicular Cancer
- Penile/Urethral Cancers
- BPH/LUTS
- Interstitial Cystitis
- Stones
- Voiding Dysfunctions
- Pediatric Urology
- Trauma and Reconstruction
- Training and Practice
- Press Releases
AUA 2015 - Renal Cancer
Viewing 1-20 of 21 articles
#AUA15 - Risk stratification for adverse outcomes following renal mass excision - Session Highlights
#AUA15 - Clinicopathologic characteristics and survival for adult renal sarcoma: a population-based study - Session Highlights
#AUA15 - Cost-effective management of small renal masses: The role of tumor biopsy - Session Highlights
#AUA15 - Perioperative aspirin use associated with an increased risk for bleeding complication following partial nephrectomy - Session Highlights
#AUA15 - Multi-quadrant biopsy technique decreases sampling error in large heterogenous tumors - Session Highlights
#AUA15 - Role of repeat biopsy in the follow-up of renal lesions with a prior non-diagnostic biopsy of the same mass - Session Highlights
#AUA15 - Vena cavoscopy in the assessment of intraluminal vena caval tumor involvement - Session Highlights
#AUA15 - Effects of perioperative variables on timing in adjuvant RCC therapy - Session Highlights
#AUA15 - Low yield of surveillance imaging after surgery for T1 kidney cancer - Session Highlights
#AUA15 - Session Highlights: Results from a multi-institutional, prospective clinical trial of delayed intervention and surveillance for small renal masses: The DISSRM Registry
#AUA15 - Can oncocytomas be safely monitored by surveillance? - Session Highlights
#AUA15 - Results from a multi-institutional, prospective clinical trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry - Session Highlights
#AUA15 - Examination of copy number alterations in renal cell carcinoma with sarcomatoid features - Session Highlights
#AUA15 - Clinical stage I renal mass upstaging to pathological T3a disease portends a worse prognosis only when sinus fat invasion is present - Session Highlights
#AUA15 - Identification of actionable targets in chromophobe renal cell carcinoma detected by multiplatform molecular analysis - Session Highlights
#AUA15 - Sarcopenia is independently associated with increased mortality following radical nephrectomy for localized renal cell carcinoma - Session Highlights
#AUA15 - Radiogenomics of clear cell renal cell carcinoma: Associations between imaging, molecular alterations and pathologic features - Session Highlights
#AUA15 - 3D printed physical models of renal malignancies for operative planning and surgical simulation - Session Highlights
#AUA15 - 3D printing of urological malignancies - Session Highlights
#AUA15 - The current and emerging role of renal biopsy for the renal mass - Session Highlights
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free